<DOC>
	<DOCNO>NCT02134665</DOCNO>
	<brief_summary>The purpose study evaluate influence severe acute pancreatitis serum level vancomycin , glycopeptide antibacterial agent .</brief_summary>
	<brief_title>Unexpected Pharmacokinetics Vancomycin Patients With Severe Acute Pancreatitis Compared With Pneumonia</brief_title>
	<detailed_description>The purpose study evaluate influence severe acute pancreatitis serum level vancomycin , glycopeptide antibacterial agent . After review 6000 clinical chart patient receive vancomycin therapy whose serum vancomycin level monitor January 2010 December 2013 , identify 212 patient also diagnose severe acute pancreatitis ( SAP group ) , 98 patient also diagnose pneumonia ( pneumonia group ) time . The fluorescence polarization immunoassay method use measure vancomycin serum trough concentration patient 30 min next administration . Using measurement , calculate pharmacokinetic parameter use Bayesian estimator .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<criteria>age 1885years old vancomycin use â‰¥ 3days age &lt; 18years old &gt; 85 year old vancomycin use &lt; 3days</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Vancomycin</keyword>
	<keyword>severe acute pancreatitis</keyword>
	<keyword>Creatinine clearance</keyword>
</DOC>